A phase 1/2 study of intravesical MK-3120 in participants with Bacillus Calmette-Guérin (BCG)-Naive or BCG-exposed high-risk non–muscle invasive bladder cancer

A phase 1/2 study of intravesical MK-3120 in participants with Bacillus Calmette-Guérin (BCG)-Naive or BCG-exposed high-risk non–muscle invasive bladder cancer

Sunday, May 17, 2026 10:04 AM to 10:12 AM · 8 min. (America/New_York)

Hall B, The Square, Learning Lab

Detail

Oncology: Bladder

Sessions

Sunday, May 17, 2026 9:00 AM to 11:00 AM

Hall B, The Square, Learning Lab

Registered attendees

Yakov Klugman

Medical StudentRoswell Park Comprehensive Cancer Center

Log in

See all the content and easy-to-use features by logging in or registering!